BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2769964)

  • 1. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
    Koike G; Otsuka T; Shibuya T; Niho Y
    Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
    Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
    Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
    Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
    Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myelogenous leukemia with marked thrombocytosis].
    Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
    Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural interferon-alpha induced cytogenetic complete remission in a patient with chronic myelocytic leukemia, diagnosed in early chronic phase with basophilia and normal blood cell counts].
    Koyama S; Moriyama Y; Aoki A; Furukawa T; Narita M; Wada K; Kishi K; Takahashi M; Koike T; Shibata A
    Rinsho Ketsueki; 1992 Feb; 33(2):227-31. PubMed ID: 1635174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concordant improvement of progressive systemic sclerosis and chronic myelogenous leukemia with interferon-alpha treatment].
    Watanabe S; Sugihara T; Takahashi M; Ata K; Kanzaki A; Yamada O; Yawata Y
    Rinsho Ketsueki; 1994 Sep; 35(9):895-7. PubMed ID: 7967060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic myelogenous leukemia with marked thrombocytosis--comparison with essential thrombocythemia with Ph1 in its megakaryokinetics].
    Kojima H; Hasegawa Y; Ikegami T; Nagasawa T; Abe T
    Rinsho Ketsueki; 1990 Jan; 31(1):35-40. PubMed ID: 2313904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].
    Koyama S; Aoki S; Furukawa T; Takahashi M; Kishi K; Koike T; Moriyama Y; Hattori A; Shibata A
    Rinsho Ketsueki; 1991 Dec; 32(12):1577-9. PubMed ID: 1779460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
    O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
    Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversible cardiomyopathy secondary to interferon-alpha in chronic myelogenous leukemia].
    Uehara E; Uesugi T; Tasaka T; Matsuhashi Y; Tamura T; Kuwajima M; Nagai M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):317-21. PubMed ID: 11865642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].
    Kitabayashi A; Miura I; Ito T; Takahashi M; Chubachi A; Niitsu H; Mamiya S; Miura AB
    Rinsho Ketsueki; 1993 Jun; 34(6):733-7. PubMed ID: 8366576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].
    Nozaki H; Usui T; Yamauchi K; Kobayashi N; Nakamura Y; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1993 Feb; 34(2):232-4. PubMed ID: 8492424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
    Maeda A; Yamamoto K; Kotone Y; Yamashita K; Yoshinaga N; Hirata H; Asagoe K; Nohgawa M; Takahashi A; Ohno H; Tashima M; Sasada M
    Rinsho Ketsueki; 1998 Jun; 39(6):442-6. PubMed ID: 9695673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myelogenous leukemia maintained in remission by interferon alpha presenting with bladder cancer].
    Kobayashi H; Ogawa T
    Rinsho Ketsueki; 1989 Jul; 30(7):1093-4. PubMed ID: 2810796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies of natural interferon alpha (HLBI) in chronic myelogenous leukemia--a multi-institutional cooperative study in Japan].
    Koyama S; Moriyama Y; Shibata A; Miura Y; Abe T; Asano S; Miyazaki T; Miura A; Kariyone S; Toyama K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2959-66. PubMed ID: 3052301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A trial for prolongation of chronic phase of chronic myeloid leukemia--maintenance of leukocyte counts within normal range with busulfan].
    Matsuo T; Tomonaga M; Kuriyama K; Jinnai I; Jubashi T; Nonaka H; Kohno T; Tsukasaki K; Atogami S; Itoyama T
    Rinsho Ketsueki; 1989 May; 30(5):625-30. PubMed ID: 2795875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
    Hasegawa A; Ninomiya H; Yanagisawa K; Takada K; Hasegawa H; Hato T; Yasukawa M; Fujita S
    Rinsho Ketsueki; 1996 Sep; 37(9):853-7. PubMed ID: 8914475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
    Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
    Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.